Abstract
Derivatives of alpha-pyrrolidone and some derivatives of adamantane possess a wide spectrum of psychotropic activity. The synthesis of adamantane and homoadamantane derivatives of alpha-pyrrolidone and the assessment of their psychotropic activity were performed. A number of framework compounds containing a pyrrolidin-2-one fragment either in the side chain or as part of the framework system were synthesized. N-(Adamantan-1-yl)pyrrolidin-2-one (TIM-2) was obtained by the reaction of 1-bromadamantane with pyrrolidin-2-one. Homoadamantane-fused pyrrolidin-2-one (TIM-1) was obtained from β-dicarbonyl derivatives of homoadamantane. Synthesis of the starting 2-(5-oxohomoadamantyl)acetic acid was carried out by cleavage of the corresponding keto diester or cyanoketo ester of homoadamantane under the conditions of the Holler–Bauer reaction with sonication. Then, the resulting γ-keto acid was introduced into the Leuckart–Wallach reaction to obtain cis-decahydro-4,8:6,10-dimethanocyclononane[b]pyrrol-2(1H)-one (TIM-1). The psychotropic activity of the obtained compounds was evaluated in standard behavioral tests in experimental animals. Compound TIM-2 exhibited pronounced anxiolytic, antidepressant, and nootropic activity. Compound binding assays were performed by molecular docking of the synthesized compounds to the GABA-B receptor, which also showed high binding energies for TIM-2.
Similar content being viewed by others
REFERENCES
Nuss, P., Neuropsychiatr. Dis. Treat., 2015, vol. 11, pp. 165–175. https://doi.org/10.2147/NDT.S58841
Tyurenkov, I.N. and Perfilova, V.N., Eksp. Klin. Farmakol., 2011, vol. 74, no. 2, pp. 47–52. https://doi.org/10.30906/0869-2092-2011-74-2-47-52
Boonstra, E., Kleijn, R., Colzato, L.S., Alkemade, A., Forstmann, B.U., and Nieuwenhuis, S., Front. Psychol., 2015, vol. 6, p. 1520. https://doi.org/10.3389/fpsyg.2015.01520
Berestovitskaya, V.M., Tyurenkov, I.N., Vasil’eva, O.S., Perfilova, V.N., Ostroglyadov, E.S., and Bagmetova, V.V., Ratsetamy: metody sinteza i biologicheskaya aktivnost’ (Racetams: Methods of Synthesis and Biological Activity), St. Petersburg: Asterion, 2016.
Spasov, A.A., Yakovlev, D.S., Brigadirova, A.A., Maltsev, D.V., and Agatsarskaya, Y.V., Russ. J. Bioorg. Chem., 2019, vol. 45, pp. 76–88. https://doi.org/10.1134/S1068162019020146
Litvin, E.A., Kolyvanov, G.B., and Zherdev, V.P., Farmakokinet. Farmakodinam., 2012, no. 1, pp. 18–24.
Štimac, A., Šekutor, M., Mlinarić-Majerski, K., Frkanec, L., and Frkanec, R., Molecules, 2017, vol. 22, no. 2, p. 297. https://doi.org/10.3390/molecules22020297
Wanka, L., Iqbal, K., and Schreiner, P.R., Chem. Rev., 2013, vol. 113, no. 5, pp. 3516–3604. https://doi.org/10.1021/cr100264t
Morozov, I.S., Ivanova, I.A., and Lukicheva, T.A., Pharm. Chem. J., 2001, vol. 35, no. 5, pp. 235–238. https://doi.org/10.1023/A:1011905302667
Artavia, G. and Lamoureux, G., Curr. Med. Chem., 2010, vol. 17, no. 26, pp. 2967–2978. https://doi.org/10.2174/092986710792065027
Spilovska, K., Zemek, F., Korabecny, J., Nepovimova, E., Soukup, O., Windisch, M., and Kuca, K., Curr. Med. Chem., 2016, vol. 23, no. 29, pp. 3245–3266. https://doi.org/10.2174/0929867323666160525114026
Spasov, A.A., Khamidova, T.V., Bugaeva, L.I., and Morozov, I.S., Pharm. Chem. J., 2000, vol. 34, no. 1, pp. 1–7. https://doi.org/10.1007/bf02524549
Shokova, E.A. and Kovalev, V.V., Pharm. Chem. J., 2016, vol. 50, no. 2, pp. 63–75. https://doi.org/10.1007/s11094-016-1400-7
Liu, J., Obando, D., Liao, V., Lifa, T., and Codd, R., Eur. J. Med. Chem., 2011, vol. 46, no. 6, pp. 1949–1963. https://doi.org/10.1016/j.ejmech.2011.01.047
Sibiryakova, A.E., Shiryaev, V.A., Reznikov, A.N., Kabanova, A.A., and Klimochkin, Y.N., Synthesis, 2019, vol. 51, no. 2, pp. 463–469. https://doi.org/10.1055/s-0037-1610824
Lavrova, L.N., Shalyminova, Yu.A., Klimova, N.V., and Artsimovich, N.G., Khim.-Farm. Zh., 1982, vol. 16, no. 10, pp. 1197–1201.
Geng, Y., Bush, M., Mosyak, L., Wang, F., and Fan, Q.R., Nature, 2013, vol. 504, no. 7479, pp. 254–259. https://doi.org/10.1038/nature12725
Armarego, W.L.F., Chemical methods used in purification, in Purification of Laboratory Chemicals, Oxford: Butterworth Heinemann Books–Elsevier, 2017, pp. 71–94, 8th ed. ISBN 9780128054574
Tkachenko, I.M., Mankova, P.A., Rybakov, V.B., Golovin, E.V., and Klimochkin, Y.N., Org. Biomol. Chem., 2020, vol. 18, no. 3, pp. 465–478. https://doi.org/10.1039/c9ob02060h
No, B.I., Mokhov, V.M., and Vishnevetskii, E.N., Russ. J. Org. Chem., 2003, vol. 39, no. 8, pp. 1193–1194. https://doi.org/10.1023/b:rujo.0000010194.16138.0b
Kurkin, D.V., Morkovin, E.I., Osadchenko, N.A., Knyshova, L.P., Bakulin, D.A., Abrosimova, E.E., Gorbunova, Yu.V., and Tyurenkov, I.N., Farm. Farmakol., 2019, vol. 7, no. 5, pp. 291–299. https://doi.org/10.19163/2307-9266-2019-7-5-291-299
Spasov, A.A., Zhukovskaya, O.N., Maltsev, D.V., Miroshnikov, M.V., Skripka, M.O., Sultanova, K.T., and Morkovnik, A.S., Russ. J. Bioorg. Chem., 2020, vol. 46, pp. 107–114. https://doi.org/10.1134/S1068162020010124
Rukovodstvo po provedeniyu doklinicheskikh issledovanii lekarstvennykh sredstv (Guidelines for Conducting Preclinical Trials of Drugs), Mironov, A.N., Ed., Moscow: Grif i K, 2013, part 1.
Funding
The synthetic part of the work was carried out with the financial support of the Ministry of Science and Higher Education of the Russian Federation within the framework of the project part of the state assignment (no. 0778-2020-0005).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
Statement on the welfare of animals. All studies were carried out in accordance with the Eurasian Economic Union legislation and technical standards for good laboratory practice (GOST (State Standards) 53434-2019 and D 51000.4-2011, Directive 2010/63/ of the European Parliament and Council of the European Union, and the interstate standard (GOST (State Standard) 33044-2014)). The study protocol was approved by the local ethics committee (Regional Research Ethics Committee of the Volgograd oblast, no. 2010–2019 dated April 2, 2019).
Conflict of Interests
The authors declare that they have no conflict of interest.
Additional information
Translated by G. Levit
Abbreviations: BBB, blood–brain barrier; CNS, central nervous system; EET, extrapolation escape test; EPM, Elevated plus maze; GABA, gamma-aminobutyric acid; PAT, Passive avoidance test; XRD, X-ray diffraction analysis; ANR-10, 4-(adamantan-1-yl)pyrrolidin-2-one; IE-1, 1-(3-hydroxyadamantan-1-yl)-pyrrolidin-2-one; TIM-1, (3aS*,10aS*)-decahydro-4,8:6,10-dimethanocyclononane[b]pyrrol-2(1H)-one; TIM-2, 1-(adamantan-1-yl)pyrrolidin-2-one.
Corresponding author: phone: +7(919)545-33-67.
Rights and permissions
About this article
Cite this article
Klimochkin, Y.N., Tkachenko, I.M., Reznikov, A.N. et al. Synthesis and Evaluation of the Psychotropic Activity of Framework Derivatives of Alpha-Pyrrolidone. Russ J Bioorg Chem 47, 1276–1287 (2021). https://doi.org/10.1134/S1068162021060108
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162021060108